Stock EEP EUROESPES, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Euroespes, S.A.

Equities

EEP

ES0133421000

Healthcare Facilities & Services

Delayed BME
Other stock markets
 10:00:11 2024-05-21 am EDT 		5-day change 1st Jan Change
0.34 EUR 0.00% Intraday chart for Euroespes, S.A. 0.00% 0.00%
2023 Euroespes, S.A. Auditor Raises 'Going Concern' Doubt CI
2023 Euroespes, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 4.487 3.54 5.971 4.133 6.098 5.797
Enterprise Value (EV) 1 8.339 3.469 7.006 5.649 8.181 9.255
P/E ratio 43.8 x -27.8 x -4.78 x -10 x -32.9 x -4.75 x
Yield - - - - - -
Capitalization / Revenue 1.31 x 1.2 x 2.38 x 1.48 x 1.58 x 1.5 x
EV / Revenue 2.44 x 1.18 x 2.79 x 2.03 x 2.12 x 2.4 x
EV / EBITDA 21.4 x -23.2 x -10.6 x -55.4 x 193 x -11.2 x
EV / FCF -68.1 x -19.3 x -17.7 x 138 x 22.6 x -14.2 x
FCF Yield -1.47% -5.18% -5.65% 0.72% 4.42% -7.06%
Price to Book 1.13 x 0.84 x 0.84 x 0.55 x 0.81 x 0.87 x
Nbr of stocks (in thousands) 5,099 5,244 10,476 10,544 11,727 11,594
Reference price 2 0.8800 0.6750 0.5700 0.3920 0.5200 0.5000
Announcement Date 4/30/18 4/23/19 8/27/20 4/30/21 4/29/22 4/28/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 3.416 2.941 2.511 2.784 3.852 3.855
EBITDA 1 0.3889 -0.1494 -0.6624 -0.102 0.0424 -0.8243
EBIT 1 0.1534 -0.3953 -0.8863 -0.3493 -0.2421 -1.117
Operating Margin 4.49% -13.44% -35.3% -12.55% -6.29% -28.97%
Earnings before Tax (EBT) 1 0.0127 -0.5309 -0.9561 -0.4295 -0.177 -1.137
Net income 1 0.1054 -0.2542 -1.258 -0.4113 -0.1834 -1.137
Net margin 3.09% -8.64% -50.12% -14.78% -4.76% -29.49%
EPS 2 0.0201 -0.0243 -0.1193 -0.0391 -0.0158 -0.1052
Free Cash Flow 1 -0.1225 -0.1798 -0.3957 0.0409 0.362 -0.6534
FCF margin -3.58% -6.11% -15.76% 1.47% 9.4% -16.95%
FCF Conversion (EBITDA) - - - - 853.06% -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/18 4/23/19 8/27/20 4/30/21 4/29/22 4/28/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 3.85 - 1.03 1.52 2.08 3.46
Net Cash position 1 - 0.07 - - - -
Leverage (Debt/EBITDA) 9.905 x - -1.563 x -14.85 x 49.08 x -4.195 x
Free Cash Flow 1 -0.12 -0.18 -0.4 0.04 0.36 -0.65
ROE (net income / shareholders' equity) 2.62% -5.01% -16.5% -5.53% -2.47% -16.7%
ROA (Net income/ Total Assets) 1.05% -2.24% -4.59% -1.89% -1.26% -5.9%
Assets 1 10.03 11.37 27.41 21.74 14.52 19.28
Book Value Per Share 2 0.7800 0.8000 0.6800 0.7100 0.6400 0.5700
Cash Flow per Share 2 0 0.3300 0.2200 0.2100 0.1700 0.0900
Capex 1 0.23 0.11 0.23 0.06 0.1 0.55
Capex / Sales 6.78% 3.71% 9.18% 2.17% 2.47% 14.39%
Announcement Date 4/30/18 4/23/19 8/27/20 4/30/21 4/29/22 4/28/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
EUROESPES, S.A. Stock Euroespes, S.A.
0.00% 3.99M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.63% 84.11B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-27.41% 71.96B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+2.32% 27.25B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-9.66% 17.31B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.96% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+3.96% 15.92B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+7.75% 13.68B
NATERA, INC. Stock Natera, Inc.
+72.83% 13.29B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+72.50% 12.73B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. EEP Stock
  4. Financials Euroespes, S.A.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW